Baldwin Wealth Partners’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.9M | Hold |
|
|||||
|
2025
Q2 | $5.07M | Sell |
|
|||||
|
2025
Q1 | $5.78M | Hold |
|
|||||
|
2024
Q4 | $4.19M | Sell |
|
|||||
|
2024
Q3 | $4.47M | Hold |
|
|||||
|
2024
Q2 | $4M | Hold |
|
|||||
|
2024
Q1 | $3.97M | Buy |
|
|||||
|
2023
Q4 | $3.9M | Buy |
|
|||||
|
2023
Q3 | $3.35M | Hold |
|
|||||
|
2023
Q2 | $3.45M | Buy |
|
|||||
|
2023
Q1 | $2.93M | Hold |
|
|||||
|
2022
Q4 | $3.66M | Sell |
|
|||||
|
2022
Q3 | $2.36M | Hold |
|
|||||
|
2022
Q2 | $2.02M | Sell |
|
|||||
|
2022
Q1 | $2.27M | Buy |
|
|||||
|
2021
Q4 | $1.58M | Hold |
|
|||||
|
2021
Q3 | $1.38M | Buy |
|
|||||
|
2021
Q2 | $1.68M | Hold |
|
|||||
|
2021
Q1 | $1.41M | Sell |
|
|||||
|
2020
Q4 | $2.06M | Buy |
|
|||||
|
2020
Q3 | $1.77M | Hold |
|
|||||
|
2020
Q2 | $2.04M | Hold |
|
|||||
|
2020
Q1 | $1.46M | Sell |
|
|||||
|
2019
Q4 | $3.64M | Buy |
|
|||||
|
2019
Q3 | $602K | Buy |
|
|||||
|
2019
Q2 | $753K | Hold |
|
|||||
|
2019
Q1 | $416K | Hold |
|
|||||
|
2018
Q4 | $82K | Sell |
|
|||||
|
2018
Q3 | $105K | Buy |
|
|||||
|
2018
Q2 | $82K | Buy |
|
|||||
|
2018
Q1 | $48K | Hold |
|
|||||
|
2017
Q4 | $109K | Hold |
|
|||||
|
2017
Q3 | $109K | Sell |
|
|||||
|
2017
Q2 | $108K | Hold |
|
|||||
|
2017
Q1 | $77K | Hold |
|
|||||
|
2016
Q4 | $133K | Buy |
|
|||||
|
2016
Q3 | $119K | Buy |
|